-
1
-
-
41349106396
-
Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City
-
Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis. 2008; 14 (3): 390-396.
-
(2008)
Emerg Infect Dis
, vol.14
, Issue.3
, pp. 390-396
-
-
Bodle, E.E.1
Cunningham, J.A.2
Della-Latta, P.3
Schluger, N.W.4
Saiman, L.5
-
2
-
-
84874397054
-
Update on the epidemiology of pulmonary nontuberculous mycobacterial infections
-
Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013; 34 (1): 87-94.
-
(2013)
Semin Respir Crit Care Med
, vol.34
, Issue.1
, pp. 87-94
-
-
Kendall, B.A.1
Winthrop, K.L.2
-
3
-
-
84886998122
-
Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010
-
Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013; 19 (11): 1889-1891.
-
(2013)
Emerg Infect Dis
, vol.19
, Issue.11
, pp. 1889-1891
-
-
Marras, T.K.1
Mendelson, D.2
Marchand-Austin, A.3
May, K.4
Jamieson, F.B.5
-
4
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
-
Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001; 345 (15): 1098-1104.
-
(2001)
N Engl J Med
, vol.345
, Issue.15
, pp. 1098-1104
-
-
Keane, J.1
Gershon, S.2
Wise, R.P.3
-
5
-
-
84907201015
-
Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada
-
Brode SK, Jamieson FB, Ng R, et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 2014; 146 (3): 563-572.
-
(2014)
Chest
, vol.146
, Issue.3
, pp. 563-572
-
-
Brode, S.K.1
Jamieson, F.B.2
Ng, R.3
-
6
-
-
84863356932
-
Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease
-
Huang CT, Tsai YJ, Wu HD, et al. Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2012; 16 (4): 539-545.
-
(2012)
Int J Tuberc Lung Dis
, vol.16
, Issue.4
, pp. 539-545
-
-
Huang, C.T.1
Tsai, Y.J.2
Wu, H.D.3
-
7
-
-
84874397842
-
Underlying host risk factors for nontuberculous mycobacterial lung disease
-
Chan ED, Iseman MD. Underlying host risk factors for nontuberculous mycobacterial lung disease. Semin Respir Crit Care Med. 2013; 34 (1): 110-123.
-
(2013)
Semin Respir Crit Care Med
, vol.34
, Issue.1
, pp. 110-123
-
-
Chan, E.D.1
Iseman, M.D.2
-
8
-
-
84874283485
-
Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011
-
de Mello KG, Mello FC, Borga L, et al. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis. 2013; 19 (3): 393-399.
-
(2013)
Emerg Infect Dis
, vol.19
, Issue.3
, pp. 393-399
-
-
De Mello, K.G.1
Mello, F.C.2
Borga, L.3
-
9
-
-
84902109958
-
Macrolide/azalide therapy for nodular/bronchiectatic: Mycobacterium avium complex lung disease
-
Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic: Mycobacterium avium complex lung disease. Chest. 2014; 146 (2): 276-282.
-
(2014)
Chest
, vol.146
, Issue.2
, pp. 276-282
-
-
Wallace, R.J.1
Brown-Elliott, B.A.2
McNulty, S.3
-
10
-
-
33744908339
-
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
-
Lam PK, Griffi th DE, Aksamit TR, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006; 173 (11): 1283-1289.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, Issue.11
, pp. 1283-1289
-
-
Lam, P.K.1
Griffi Th, D.E.2
Aksamit, T.R.3
|